Volume : 09, Issue : 10, October – 2022
Title:
07.OVERALL REVIEW AND EVALUATION OF PAEDIATRIC ASTHMA
Authors :
Senthilpandi. K*, Swarnapriya.S, Ramnath.E, Tivyalakshmi.S. T, Fathima Basheera.M
Abstract :
Asthma is defined as a habitual seditious complaint of the airways. The habitual inflammation is associated with airway hyperresposiveness (an inflated airway- narrowing response to specific triggers similar as contagions, allergens and exercise) that leads to intermittent occurrences of gasping, breathlessness, casket miserliness and/ or coughing that can vary over time and in intensity. Viral respiratory tract infections, Exercise, Weather changes in temperature and humidity, Domestic pollutants (eg, pests, mould and dust mites), Environmental pollutants (eg, air pollution), Secondhand smoke exposure, Pets and animals, etc.. are the common factors that triggers asthma in children. Personal or family history of atopy: eczema, allergic rhinitis or nasal polyposis, Family history of asthma, Exposure to secondhand smoke, Preterm birth, Low birth weight, Obesity, Poor housing quality/mould and dampness, Air pollution are the risk factors associated with asthma. The pathophysiology involved in asthma is the infiltration of inflammatory cells (neutrophils, eosinophils, and lymphocytes) into the airway, activation of mast cells, and damage to epithelial cells. These responses leads to airway swelling, increased mucus secretion, and bronchial dysfunction which produce airway flow limitation and asthma symptoms. Paroxysms of dypnoea, intermittent occurrences of gasping, Coughing (particularly at night or in the early morning), casket miserliness and Sleep dislocation are the signs associated with asthma in children. The treatment involved in asthma includes Oxygen for hypoxia, inhaled and oral corticosteroids, leukotriene receptor antagonist, long-acting beta2-agonist, immunoglobulin E.
Key words: Asthma, Inflammation, Airway, IgE, Corticosteroids, Pulmonary function.
Cite This Article:
Please cite this article in K. Senthilpandi et al, Overall Review And Evaluation Of Paediatric Asthma., Indo Am. J. P. Sci, 2022; 09(10).
Number of Downloads : 10
References:
1. Ibrahim C, Singh K, Tsai G, Huang D, Mazza J, Rotenberg B, Kim H, Moote DW. A retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma. Allergy, Asthma & Clinical Immunology. 2014 Dec;10(1):1-6.
2. Corrales AY, Soto-Martinez M, Starr M. Management of severe asthma in children. Australian family physician. 2011 Jan;40(1/2):35-8.
3. Sachdev A, Gupta N. Acute severe asthma in children.
4. Mohan H. Textbook of pathology. Jaypee Brothers Medical Publishers; 2018 Nov 30.Bronchial asthma:463
5. Subbarao P, Mandhane PJ, Sears MR. Asthma: epidemiology, etiology and risk factors. Cmaj. 2009 Oct 27;181(9):E181-90.
6. Martin J, Townshend J, Brodlie M. Diagnosis and management of asthma in children. BMJ paediatrics open. 2022;6(1).
7. Network GA. The global asthma report 2014. Auckland, New Zealand. 2014;769:28-36.
8. To T, Stanojevic S, Moores G, Gershon AS, Bateman E, Cruz AA, Boulet LP. Global asthma prevalence in adults: findings from the cross-sectional world health survey https://www. ncbi. nlm. nih. gov/pmc/articles. PMC3353191. 2012.
9. Sol IS, Jang H, Noh J, Kim SY, Kim MJ, Kim YH, Kim C, Sohn MH, Kim KW. Mortality and morbidity in children with asthma: A nationwide study in Korea. Respiratory Medicine. 2021 Feb 1;177:106306.
10. Mohan H. Textbook of pathology. Jaypee Brothers Medical Publishers; 2018 Nov 30.Bronchial asthma:464
11. Robbins KV. Cotran Pathologic basis of Disease 9th edition/Kumar V., Abbas AK, Aster JC-Canada.681
12. Sean Holt, MBBS,a Matthew Masoli, MRCP,b and Richard Beasley, DM,b,c Wellington,New Zealand , and Southampton, United Kingdom, increasing compliance with inhaled corticosteroids through the use of combination therapy; review and feature articles.
13. Ajay Punj, Ashish Prakash and Ashu Bhasin, Department of Pediatrics, Subharti Institute of Medical Sciences, Meerut, U.P. India, Levosalbutamol vs Racemic Salbutamol in the Treatment of Acute Exacerbation of Asthma;[Indian J Pediatr 2009; 76 (11) : 1131-1135]
14. Sayid M Barkiya1, Veena Kumari2, Venugopal N2,Abdul aseeze3 – Effects of Aerosolized Levosalbutamol Verses Salbutamol on Serum Potassium Level and Heart Rate in Children with Acute Exacerbation of Asthma; International Journal of Scientific Study | February 2016 | Vol 3 | Issue 11,pgno 223-227.
15. L. B. Bacharier1, A. Boner2,K.-H. Carlsen3,et al Review article-Diagnosis and treatment of asthma in childhood: a PRACTALLconsensus report; _ 2008 The Authors journal compilation _ 2008 Blackwell Munksgaard; 5–34.
16. Jaclyn quirt, Kyla. J. Hildebrand, et al ,Review allergy,asthma and clinical immunology; Quirt et al. Allergy Asthma Clin Immunol 2018, 14(Suppl 2):50.
17. Management of Asthma in Children JAMES P. KEMP, M.D., University of California School of Medicine, San Diego, California JUDITH A. KEMP, D.O., San Diego, California (Am Fam Physician 2001;63:1341-8,1353-4.);
18. Faiqa Qureshi, MD, Arno Zaritsky, MD, and Michael P. Poirier, MD;Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma; (J Pediatr 2001;139:20-6)
19. Elliot F.Ellis, M.D. Buffalo, N.Y-.Asthma in childhood ; (J ALLERGY CLIN IMMUNOL 72.526539, 1983. 20. Wim. M. Aalderen, department of pediatric diseases and allergy; Review article childhood
20. Kumar V, Abbas AK, Aster JC. Robbins basic pathology e-book. Elsevier Health Sciences; 2017 Mar 8. Asthma:504
21. Pharmacotherapy ,joseph t dipiro(pg no;823-834)
22. 9. R. DAHL, et al-.Monitoring of brochial asthma; RESPIRATORY MEDICINE (1997) 91, 581-586
23. Pubmed: Diagnosis of bronchial asthma
24. LARS J GRIMM, MD, MHS,et al – Asthma imaging and diagnosis(dec28,2020)Medscape.com
25. Rodriguez-Roisin R. Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. European Respiratory Journal. 1997 Jun 1;10(6):1359-71.
26. Øymar K, Halvorsen T. Emergency presentation and management of acute severe asthma in children. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2009 Dec;17(1):1-1.
27. Allen DB. Effects of inhaled steroids on growth, bone metabolism and adrenal function. Expert Rev Respir Med 2007;1:65-74.
28. Rowe BH, Keller JL, Oxman AD. Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med 1992;10:301- 10.
29. Scarfone RJ, Fuchs SM, Nager AL, Shane SA. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics 1993;92:513-8.
30. Barnett PLJ, Caputo GL, Baskin M, Kupperman N. Intravenous versus oral corticosteroids in the management of acute asthma in children. Ann Emerg Med 1997;29:212-7.
31. Barsky EE, Giancola LM, Baxi SN, Gaffin JM. A practical approach to severe asthma in children. Ann Am Thorac Soc 2018;15:399-408
32. Pedersen S. Do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med 2001;164:521-35.
33. Schuh S, Reisman J, Alsherhri M, Dupuis A, Corey M, Arseneault R, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 2000;343:689-94.
34. Engelhardt A. Pharmacology and toxicology of Atrovent. Scand J Respir Dis 1979;103:110-5.
35. Schultz A, Martin AC. Outpatient management of asthma in children. Clinical Medicine Insights: Pediatrics. 2013 Jan;7:CMPed-S7867
36. National Asthma Education and Prevention Program Expert Panel report 2: guidelines for the diagnosis and management of asthma. NIH—publication no. 97-4051. Bethesda, MD: US Department of Health and Human Services, 1997.
37. Lipworth BJ. Risk versus benefits of inhaled β2-agonists in the management of asthma. Drug Safety 1992;7:54-70.
38. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, eds. Goodman & Gilman’s the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996;199-248.
39. Goggin N, Macarthur C, Parkin PC. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Arch Pediatr Adolesc Med. 2001;155(12):1329–34.
40. Lougheed MD, Lemière C, Dell SD, Ducharme FM, Fitzgerald JM, Leigh R,Licskai C, Rowe BH, Bowie D, Becker A, Boulet LP: Canadian ThoracicSociety asthma management continuum: 2010 consensus summary forchildren six years of age and over, and adults. Can Respir J 2010,17:15-24.
41. Quirt A, Hildebrand KJ, Mazza J, Noya F, Kim H. Allergy Asthma Clin.